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中年の日本人における上下肢生体インピーダンス法 
による四肢の骨格筋量の正確な評価
An accurate estimation of appendicular skeletal muscle mass by simple bioelectrical 
impedance method between the upper and lower limbs in middle-aged Japanese
Tetsuya Sato, Yuki Hotta, Moeki Wada, Momoko Akamine,  
Misora Ao, Hiroyuki Nishikawa, Takashi Miyawaki
Summary
Objectives: This study aimed to develop a skeletal muscle mass prediction formula for the upper and lower limbs 
using bioelectrical impedance (BI) method, and to investigate the relation to the atherosclerosis risk factors.
Methods: This study was in two parts. First, a new device using the skeletal muscle mass prediction formula for the 
upper and lower limbs was developed using the data of 1197 healthy males and females in whom BI, height, weight, 
and skeletal muscle mass were measured. Dual energy X-ray absorptiometry (DXA) was used as the reference 
method. Second, using the device with the developed prediction formula, we measured BI, waist circumference, and 
the atherosclerosis risk factors in 1161 untreated males and females who underwent an annual medical check-up and 
investigated the association of the number of atherosclerosis risk factors and the skeletal muscle mass index (SMI).
Results: The correlation between the estimated skeletal muscle mass and DXA of the upper and lower limbs were 
0.94 and 0.95, respectively (P < 0.001 for both). In males with a waist circumference less than the standard value 
(85cm), the number of atherosclerosis risk factors was significantly correlated with SMI of the lower limbs 
(B = − 0.109, P = 0.011). The cutoff values of SMI of the upper and lower limbs for males and females as a pre-
dictor of the presence of at least two of the atherosclerosis risks factors were 8.4 kg/m2 and 6.5 kg/m2, respective-
ly. These cutoff values were higher than the cutoff for sarcopenia (7.0kg/m2  for males and 5.7kg/m2  for females).
Conclusions: A new device using the skeletal muscle mass prediction formula for the upper and lower limbs with 
a high degree of accuracy. It is suggested that the decrease in skeletal muscle causes atherosclerosis earlier than 
sarcopenia in middle-aged Japanese. (Received 4 October, 2019, Accepted 25 November)
1.  Introduction
Sarcopenia is defined as the age-related decline in 
skeletal muscle mass [1]. It is well known that the cross-
sectional area of skeletal muscle is decreased by 25%–30%, 
and the muscle strength is decreased by 30%–40% in 
individuals who are 70 years old compared with the people 
in their twenties. In addition, the muscle mass decreases at 
a rate of 1%–2% every year after the age of 50 years [2].
Currently, the recommended criteria for the diagnosis of 
sarcopenia requires documentation for low appendicular 
skeletal muscle mass (ASM) and low muscle strength or 
low physical performance [3, 4]. ASM is defined by the 
sum of the lean soft tissue mass from the four limbs [5]. 
Furthermore, the height-adjusted muscle mass was a more 
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suitable skeletal muscle index (SMI) for assessing sarco-
penia among Asian populations [6, 7]. Therefore, the SMI 
is calculated by the appendicular skeletal muscle mass di-
vided by height (m) squared (ASM / height2; kg/m2); This 
equation was used in the current study on sarcopenia, for 
which the cutoff values of SMI, measured by BI method, 
are 7.0kg/m2 for males and 5.7kg/m2 for females [8].
In 2010, The European Working Group on Sarcopenia 
in Older People recommended using magnetic resonance 
imaging (MRI), computed tomography (CT), dual energy 
X-ray absorptiometry (DXA), and bioelectrical imped-
ance analysis (BIA) as suitable methods for measuring 
muscle mass for sarcopenia research [3]. MRI and CT are 
the gold standards for estimating muscle mass in research. 
DXA and BIA are the preferred alternative method for re-
search and clinical use. Therefore, ASM is commonly 
measured using DXA or BIA. BIA method is simple, 
easy, and does not involve radiation exposure to the sub-
ject. Several sarcopenia studies using BIA devices as di-
agnosis tools have been reported [9-13]; however, their 
methods for calculating ASM using BIA devices were not 
disclosed [14]. Due to the size of these devices, they are 
usually only used to measure ASM at medical institutions.
The previous studies have reported that the skeletal 
muscle mass is not only related to sarcopenia but also ath-
erosclerosis risk [15, 16]. In an earlier paper, we reported 
that visceral fat area and skeletal muscle percentage are 
independent risk factors for atherosclerosis [17]. We de-
veloped a BIA device for measuring the SMI in the upper 
and lower limbs and examined the association between 
atherosclerosis risk and SMI as the clinical application of 
the device. Our study was conducted in two parts. The 
purpose of the first part of our study was to develop the 
formula to use with the new BI device for the prediction 
of lean soft tissue mass (LSTM) as skeletal muscle mass 
in upper limbs and lower limbs respectively using the BIA 
method in reference to LSTM of DXA within the guide-
line. The purpose of the second part of our study was to 
investigate the relationship between skeletal muscle mass 
in upper limbs and lower limbs and atherosclerosis risk.
2.  Methods
2. 1.  Study 1
2. 1. 1  Subjects
We enrolled 1,197 healthy Japanese adults aged 20–80 
years (536 males and 661 females). The subjects were 
randomly separated into the validation group (268 males 
and 331 females) or the cross-validation group (268 
males and 330 females) so that there were no significant 
age differences between the two groups.
2. 1. 2.  Anthropometric measurements
The body weight of each subject was measured to the 
nearest 0.1 kg with the subject in light clothes, and the 
height was measured to the nearest 0.1 cm. From these 
measurements, the body mass index (BMI) and body sur-
face area (BSA) were calculated [18].
2. 1. 3.  Dual energy X-ray absorptiometry measurement
DXA measurements of LSTM were performed using a 
Lunar DPX-LIQ (Lunar Co., Madison, WI, USA; soft-
ware version 4.7E). The subjects were scanned with their 
arms down and lying in the supine position. The total 
body scan took less than 15 minutes to complete.
2. 1. 4.  Bioelectrical impedance measurement
Bioelectrical impedance (BI) was measured in the up-
per and lower limbs using the HBF-354 prototype (OM-
RON Healthcare Co. Ltd., Kyoto, Japan) [18]. The 
equipment used for impedance (Z) measurements includ-
ed handgrips and footplate electrodes. Each electrode 
was connected to the main unit by cables.
The different types of Z measurements taken using this 
method included the following: whole-body Z between 
the upper and lower limbs (Zw), Z between right hand 
and left hand (Zh), and Z between right foot and left foot 
(Zf). Zw was determined by measuring the voltage in-
duced by applying a current to electrodes fixed on the bi-
lateral palms and soles while shorting each electrode 
with the bilateral palms and soles in the standing position 
and the upper limbs extended forward. A constant current 
of 500 μA at 50 kHz was applied. The three BI indices 
were calculated as height2/Zw, height2/Zh, and height2/Zf.
2. 1. 5.  Statistical analysis
All statistical analyses were performed using SPSS 
Statistics version 21 for Windows (IBM Corp., Armonk, 
NY). Data are presented as the mean ± standard devia-
tion, and statistical significance was set at P < 0.05. We 
used the Mann-Whitney U test to assess significant dif-
ferences between the groups, and Spearman’s correlation 
coefficient to assess correlations between the two vari-
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ables when the values were not normally distributed. 
Stepwise multiple linear regression analysis was used 
to develop the prediction equation for determining LSTM 
of the upper and lower limbs using three BI indices, gen-
der, age, height, body weight, BMI, and BSA as indepen-
dent variables as described in our previous study [18].
The predicted values for LSTM were calculated for the 
individuals in the cross-validation group using the equa-
tions derived for the validation group. The differences 
between the DXA-measured and BIA-predicted LSTM 
measurements were determined using a paired t-test.
2. 2.  Study 2
2. 2. 1.  Subjects
We enrolled a total of 1441 adults (1250 males and 191 
women; mean age ± SD, 50.3 ± 7.2 and 49.3 ± 8.8 years, re-
spectively), who had undergone an annual medical check-
up at a health check-up center in the Kinki area of Japan be-
tween February 2012 and April 2015. We excluded 252 
males and 28 females that were taking antihypertensive 
agents, antidiabetic agents, and lipid-lowering agents, or 
who had dehydrative or edematous diseases. The final study 
included 1161 adults (998 males and 163 females; mean age 
± SD, 49.4 ± 7.4 and 48.2 ± 8.9 years, respectively).
2. 2. 2.   Anthropometric and atherosclerosis risk factor 
assessments
Each morning, the body weight of each subject was 
measured to the nearest 0.1 kg, with the subject in light 
clothes, and the height was measured to the nearest 0.1 
cm. The waist circumference (WC) was measured by a 
well-trained examiner to the nearest 0.5 cm at the umbili-
cal level during the late exhalation phase while the subject 
was standing. Blood pressure measurements were obtained 
in the morning while the subjects were resting in a seated 
position. Blood samples were collected, after an overnight 
fast, for assessment of fasting plasma glucose, triglyceride, 
and high-density lipoprotein (HDL)-cholesterol levels.
2. 2. 3.  Diagnosis of atherosclerosis risk factors
We used hypertension, diabetes, and dyslipidemia as 
an assessment of atherosclerosis. The diagnosis of ath-
erosclerosis risk factors was performed in accordance 
with the definitions provided by the Examination Com-
mittee of Criteria for the Metabolic Syndrome in Japan 
[20, 21]. Hypertension was defined as systolic blood 
pressure ≥130 mmHg and/or diastolic blood pressure ≥85 
mmHg; diabetes diagnosis was defined as a fasting plas-
ma glucose level ≥110 mg/dL; and dyslipidemia was de-
fined as a triglyceride level ≥150 mg/dL and/or 
HDL-cholesterol level <40 mg/dL.
2. 2. 4.  Statistical analysis
Multicollinearity analyses were performed using SMI, 
age, and WC as variables. Explanatory variables with a 
low contribution rate were excluded from the analysis. 
Multiple linear regression analysis was performed to de-
termine the relative contribution of explanatory variables 
to the response variable (number of risk factors), grouped 
by the presence or absence of WC criteria. To identify 
the optimal appendicular SMI for predicting at least two 
components of the metabolic syndrome, we performed 
receiver operating characteristic (ROC) analysis. The 
best cutoff value was determined by the Youden index. 
The other analyses are the same as described for study 1.
3.  Results
3. 1.  Study 1
The subject characteristics are presented in Table 1. 
The mean age, height, weight, and BMI were not signifi-
cantly different between the validation group and the 
cross-validation group in both males and females.
According to the results of stepwise multiple regres-
sion analyses, the BI index of Zh, BSA, and gender were 
Table 1.  Physical characteristics of the subjects in study 1
Males Females
Validation group Cross-validation group P value Validation group Cross-validation group P value
n 268 268 331 330
Age (year) 39.2 ± 13.6 39.3 ± 13.7 0.92 39.7 ± 12.9 39.6 ± 12.7 0.97
Height (cm) 170.3 ± 6.2 170 ± 6.3 0.90 158 ± 5.6 158 ± 5.5 0.79
Weight (kg) 68.9 ± 12.2 68.5 ± 10.8 0.94 56.4 ± 10.1 56.2 ± 10.1 0.77
BMI (kg/m2) 23.7 ± 3.7 23.7 ± 3.4 0.96 22.6 ± 3.9 22.5 ± 3.8 0.91
Values are presented as mean ± standard deviation.
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selected as significant contributors for predicting the 
LSTM of upper limbs, and the BI index of Zw, age, and 
height were selected as significant contributors for pre-
dicting the LSTM of lower limbs. Regression analyses 
showed the prediction equation as follows:
 LSTM of upper limbs (kg)  
=  (0.086 × BI index of Zh) + (0.518 × BSA)  
+ (−0.520 × gender) − 2.115,
 LSTM of lower limbs (kg)  
=  (0.143 × BI index of Zw) + (−0.035 × age)  
+ (0.085 × height) – 9.541,
where age is in years. Gender for male = 1 and female = 2.
The relationship between the BIA-predicted and 
DXA-measured LSTM measurements in the validation 
group is shown in Table 2. There was a significant posi-
tive correlation between the LSTM measurements for 
upper and lower limbs predicted by BIA and the LSTM 
measurements performed using DXA (upper, r = 0.942, 
P < 0.001; lower, r = 0.950, P < 0.001).
The prediction equation derived from the validation 
group was used to predict LSTM measurements in the 
cross-validation group. There were significant correla-
tions between measured and predicted LSTM values, re-
spectively (Table 2). Analyses also showed that the 
LSTM values of upper and lower limbs predicted by BIA 
were significantly correlated with the LSTM measure-
ments taken by DXA (upper, r = 0.944, P < 0.001; lower, 
r = 0.949, P < 0.001).
All data was pooled to generate the final regression 
equation:
 LSTM of upper limbs (kg) = (0.088 × BI index of Zh) 
+ (0.480 × BSA) + (−0.554 × gender) − 1.851,
 LSTM of lower limbs (kg) = (0.144 × BI index of Zw) 
+ (−0.032 × age) + (0.086 × height) – 9.877,
where age is in years. Gender for males = 1 and fe-
males = 2.
The r and standard error for estimating the regression 
equation for upper and lower limbs were 0.943 (P < 0.001), 
0.950 (P < 0.001) and 0.42kg, 0.96kg, respectively (Table 2).
3. 2.  Study 2
The subject characteristics are presented in Table 3. 
The mean height, body weight, BMI, and WC were sig-
Table 2. The correlation between LSTM estimated by BIA method and LSTM by DXA
Validation group
(n = 599)
Cross-validation group
(n = 598)
All subjects
(n = 1197)
Upper limbs Lower limbs Upper limbs Lower limbs Upper limbs Lower limbs
r 0.942 0.950 0.944 0.949 0.943 0.950
SEE (kg) 0.50 0.96 0.47 0.94 0.42 0.96
P value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
SEE: Standard error of estimate
Table 3.  Clinical characteristics of subjects in study 2
Males Females P value
Number 998 163
Age (year) 49.4 ± 7.4 48.2 ± 8.9 0.216
Height (cm) 171.4 ± 5.8 158.7 ± 5.2 <0.001
Weight (kg) 68.9 ± 9.1 57.3 ± 8.7 <0.001
BMI (kg/m2) 23.4 ± 2.7 22.7 ± 3.3 <0.001
Waist circumference (cm) 84 ± 7.5 79.7 ± 8.9 <0.001
SBP (mmHg) 122.9 ± 15.6 112.6 ± 17 <0.001
DBP (mmHg) 78.3 ± 10 70.9 ± 11 <0.001
FPG (mg/dl) 102.9 ± 10.8 99.7 ± 10 <0.001
TG (mg/dl) 125.6 ± 102.1 85.7 ± 54.6 <0.001
HDL-C (mg/dl) 60.2 ± 14.6 67.8 ± 14.5 <0.001
LSTM upper and lower limbs (kg) 24.0 ± 2.3 16.5 ± 1.7 <0.001
      upper limbs (kg) 6.1 ± 1.9 3.8 ± 0.6 <0.001
      lower limbs (kg) 17.8 ± 2.3 12.8 ± 1.4 <0.001
SMI upper and lower limbs (kg/m2) 8.2 ± 0.6 6.6 ± 0.5 <0.001
      upper limbs (kg/m2) 2.1 ± 0.2 1.5 ± 0.2 <0.001
      lower limbs (kg/m2) 6.0 ± 0.4 5,1 ± 0.4 <0.001
number of risk factors  0　 431 118
1　 373 33　
2　 160 9　
　 3　 34　 　 　 3　 　 　
Values are presented as mean ± standard deviation.
SBP: systolic blood pressure, DBP: diastolic blood pressure, FPG: fasting plasma glucose, TG: triglyceride, 
HDL-C: HDL-cholesterol, LSTM: lean soft tissue mass, SMI: skeletal muscle index
令和元年12月（2019年） ― 29 ―
nificantly higher in the males compared to the females. 
There were no significant differences in the mean age be-
tween the males and females.
Table 4 shows the results of multiple linear regression 
analyses for determining the relationship between the 
number of atherosclerosis risk factors and SMI, age, and 
WC. There was multicollinearity between BMI measure-
ments, and the contribution rate of BMI was lower than 
that of WC. Therefore, BMI was excluded from the anal-
ysis. The number of atherosclerosis risk factors was sig-
nificantly correlated with the SMI of lower limbs 
(B = -0.164, P < 0.001) in males with WC < 85 cm. 
Whereas in males with other combinations, the number 
of risk factors was significantly correlated with age and 
WC, but not SMI. In females, there was no significant 
correlation between the number of risk factors and SMI.
We performed gender-specific ROC analyses to assess 
appendicular SMI as an indicator of at least two of the 
Table 4.   Results of the multiple linear regression analysis of the relationship between number of atherosclerosis risk factors and 
SMI, age, and waist circumference (WC)
Males Females
WC < 85 cm WC ≥ 85 cm WC < 90 cm WC ≥ 90 cm
(n = 558) (n = 440) (n = 142) (n = 21)
B P value B P value B P value B P value
SMI_a -0.066 0.136 0.070 0.186 -0.029 0.776 -0.011 0.961
Age 0.261 <0.001 0.177 <0.001 0.255 0.002 0.422 0.045
WC 0.235 <0.001 0.167 0.002 0.269 0.011 0.424 0.066
Males Females
WC < 85 cm WC ≥ 85 cm WC < 90 cm WC ≥ 90 cm
(n = 558) (n = 440) (n = 142) (n = 21)
B P value B P value B P value B P value
SMI_u -0.017 0.703 0.083 0.186 -0.136 0.141 0.039 0.859
Age 0.255 <0.001 0.175 <0.001 0.248 0.002 0.436 0.050
WC 0.215 <0.001 0.163 0.002 0.325 0.001 0.405 0.082
Males Females
WC < 85 cm WC ≥ 85 cm WC < 90 cm WC ≥ 90 cm
(n = 558) (n = 440) (n = 142) (n = 21)
B P value B P value B P value B P value
SMI_l -0.109 0.011 0.036 0.489 -0.105 0.233 0.040 0.850
Age 0.260 <0.001 0.177 <0.001 0.244 <0.001 0.440 0.045
WC 0.247 <0.001 0.183 0.001 0.300 0.001 0.411 0.065
Objective variable: number of risk factors, Explanatory variable: SMI_a or SMI_u or SMI_l, age, and WC
B: standardized partial regression coefficient, SMI_a: Skeletal muscle mass index of upper and lower limbs, SMI_u: Skeletal muscle mass index of 
upper limbs, SMI_l: Skeletal muscle mass index of lower limbs, WC: waist circumference
Fig 1.   Gender-specific ROC for using SMI to detect the presence of at least two components of metabolic 
syndrome (raised TG and /or reduced HDL-C, raised BP, and raised FPG).
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three components of metabolic syndrome (Figure 1). The 
sensitivity and the specificity of SMI cutoff values for 
males and females were 8.4 kg/m2 and 6.5 kg/m2, respec-
tively. Furthermore, these cutoff values were higher than 
the cutoff of sarcopenia (7.0kg/m2 for males and 5.7kg/m2 
for females) [8].
4.  Discussion
In this study, we developed the first simple BIA device 
able to measure the skeletal muscle mass of the upper 
and lower limbs separately, and the prediction formula is 
disclosed. This study is the first report comparing risk 
factors for atherosclerosis and SMI, and determining the 
cutoff value of SMI for determining atherosclerosis. 
These results suggest that a decrease of skeletal muscle 
contributes to atherosclerosis risk earlier than that of sar-
copenia in middle-aged subjects.
From the results of the study 1, where the prediction 
formulas derived from the validation groups were applied 
to the cross-validation groups, the LSTM values predict-
ed by the BIA methods were strongly correlated with 
those measured using DXA. These results suggest that 
the BIA method used to measure the LSTM of upper and 
lower limbs is the simple and practical method for pre-
dicting LSTM.
From the results of the multiple regression analyses in 
study 2, it was suggested that WC and age had the stron-
gest association with atherosclerosis risk factors among 
the males (WC< 85cm). Also, the SMI of the lower limbs 
was the second largest contributing factor next to WC 
and age, in the male subjects. However, in the female 
subjects, the number of risk factors was not significantly 
correlated with SMI. The reasons for the gender differ-
ences in the predictive variables might be due to the low-
er overall volume of muscle mass in the females com-
pared to the males. Therefore, the contribution of muscle 
mass is lower in females than in males. A second factor 
contributing to this difference might be the influence of 
sex hormones. The male hormone testosterone has been 
shown to induce skeletal muscle protein anabolism and 
increase muscle size and strength [22]. Meanwhile, estro-
gen, a female hormone, has been associated with de-
creased atherosclerosis risk [23].
Skeletal muscle is the largest tissue in human body and 
plays an important role in energy metabolism, glucose 
uptake, and physical activity. Approximately 15% of the 
circulating blood volume is supplied to skeletal muscle at 
rest, and approximately 20% of the oxygen used in the 
body is consumed by skeletal muscle [24]. Glucose in the 
blood is carried to skeletal muscle, and metabolized in 
the presence of oxygen [24]. A previous study has report-
ed that the muscles of the upper limbs, which carry the 
marginal gravitational load, show less adaptation com-
pared to the muscles of the lower limbs after unloaded 
inactivity [25]. Muscle mass of lower limbs is greater 
than that of the upper limbs. Other previous studies have 
reported that the loss of skeletal muscle mass with aging 
was greater in the lower body compared to the upper 
body [26]. Therefore, it is assumed that skeletal muscles 
of the lower limbs are more important for motor and met-
abolic function compared to  muscles of the upper limbs.
The exact mechanism by which the decrease in skele-
tal muscle mass leads to the development of atheroscle-
rosis risk is not fully understood. It is possible that insu-
lin resistance, which leads to decrease in skeletal muscle 
mass, also leads to the development of atherosclerosis 
risk factors such as diabetes, dyslipidemia, and hyperten-
sion [27]. Skeletal muscle is responsible for a major part 
of insulin-stimulated disposal of glucose in the body and 
it plays an important role in the pathogenesis of insulin 
resistance. Previous studies revealed that decrease in the 
skeletal muscle mass caused a decline and hypofunction 
of mitochondria in skeletal muscle [17, 28]. Skeletal 
muscle mitochondrial dysfunction is involved in the ac-
cumulation of intra-myocellular lipid metabolites. When 
this occurs, fatty acids in skeletal muscle are not metabo-
lized, and it becomes an insulin resistance risk factor [28, 
29]. As for future studies, it is necessary to explore the 
molecular mechanisms associated with the development 
of atherosclerosis risk that is associated with decreased 
skeletal muscle mass.
The BIA method for measuring the LSTM in the upper 
and lower limbs in this study has potentials for clinical 
applications [30-35]. Since our BIA method uses only 
two kinds of impedance, the total time required for mea-
surement is about 5 seconds. The measurement system is 
simple, low-cost, and compact (it weighs approximately 
2 kg and measures 30cm-square), and it would lead to an 
easy detection of decrease in skeletal muscle mass at 
home.
The device used in this study has some limitations. 
First, the BIA method, in general, it affected by the water 
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volume in the body, therefore dehydration and edema 
[36] or within-day variability may affect the results of the 
measurements [37]. Then, measured values may not be 
accurate in the subjects with edema or in the dialysis 
subjects. 
Considering within-day variability, our BIA device did 
not previously show within-day variability [37]. Howev-
er, it may be preferable to measure the impedance at reg-
ularly scheduled times for accuracy. 
Second, with the measuring position, it is not adapt-
able for those who cannot keep a standing position. 
In addition, we have to consider the other limitations. 
First, the participants in this study were only Japanese 
people. 
Second, the participants were enrolled so that each 
generation became almost equal, therefore, the partici-
pant group has few ratios of the elderly person who may 
be develop sarcopenia.
Third, we did not evaluate the functional aspects of the 
skeletal muscle, such as muscle strength, and exercise 
habits. Muscle strength training has been reported to re-
duced metabolic syndrome risk [38]. Further studies on 
the evaluation of muscle strength based on the criteria for 
diagnosing sarcopenia should be performed.
In conclusion, the BIA method for predicting LSTM 
presented in this study are accurate and simple , then may 
be useful for assessing the muscle mass of upper and 
lower limbs. Therefore, a new device using the skeletal 
muscle mass prediction formula for the upper and lower 
limbs will make it probable to determine the extent of 
sarcopenia and to predict atherosclerosis risk at home.
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和文抄録
目的：本研究は，生体インピーダンス（BI）法を用いて，上肢および下肢それぞれの骨格筋量の推
定式を搭載した機器を開発し，動脈硬化リスク因子との関係を調査することを目的とした。
方法：研究 1 として，20 ～ 80 歳の健康な男女 1197 名のデータを用いて，上肢および下肢の骨格筋
量の推定式を開発した。各々の被験者は，生体インピーダンス，身長および体重を測定し，骨格
筋量のリファレンスは二重エネルギー X 線吸収測定法（DXA）を用いて測定した。研究 2 として，
未治療の男女の人間ドック健診受診者 1161 人を対象として，前記で開発した骨格筋量の推定式を
インストールした装置を用いて上肢および下肢の骨格筋量を推定し，腹囲および動脈硬化リスク
因子も測定した。次に，上肢および下肢の骨格筋量から骨格筋量指数（SMI）を算出し，目的変数
を動脈硬化リスク数，独立変数を SMI，年齢，および腹囲とし重回帰分析を行った。さらに，動
脈硬化リスク数が 2 以上となる上下肢 SMI のカットオフ値を ROC 解析を用いて求めた。
結果：研究 1 では，骨格筋量の推定値とリファレンスの DXA の相関係数は上肢と下肢がそれぞれ 0.94
と 0.95（P< 0.001）であった。研究 2 では，腹囲が基準値の 85cm 未満の男性において，下肢の
SMI の減少は動脈硬化リスク数の有意な寄与因子であった（B =－0.109， P = 0.011）。また，動脈硬
化リスクが 2 個以上となる上下肢 SMI のカットオフ値は男女それぞれ 8.4kg/m2 と 6.5kg/m2 であり，
サルコペニア診断基準のカットオフ値（男性：7.0kg/m2 ，女性：5.7kg/m2）より高値であった。
結論：今回作成した推定式は，上肢および下肢それぞれの骨格筋量を高い精度で推定することが可
能であった。動脈硬化リスクを評価する体組成の測定においては，従来の BMI や内臓脂肪蓄積の
評価に加えて，上下肢別に SMI を評価することが重要であると考えられた。骨格筋の減少に伴い，
動脈硬化リスクはサルコペニアリスクより早期に生じる可能性が示唆された。
